The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration - Archive ouverte HAL Access content directly
Journal Articles Clinical Kidney Journal Year : 2021

The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration

(1) , (1) , (1) , (2) , (2) , (3) , (4, 5) , (1) , (1)
1
2
3
4
5

Abstract

BACKGROUND: C-type natriuretic peptide (CNP) and its co-product N-terminal proCNP (NTproCNP) have been associated with beneficial effects on the cardiovascular system. In prevalent dialysis patients, however, a relation between NTproCNP and mortality has not yet been investigated. Furthermore, as a middle molecular weight substance, its concentration might be influenced by dialysis modality. METHODS: In a cohort of patients treated with haemodialysis (HD) or haemodiafiltration (HDF), levels of NTproCNP were measured at baseline and 6, 12, 24 and 36 months. The relation between serum NTproCNP and mortality and the relation between the 6-month rate of change of NTproCNP and mortality were analysed using Cox regression models. For the longitudinal analyses, linear mixed models were used. RESULTS: In total, 406 subjects were studied. The median baseline serum NTproCNP was 93 pmol/L and the median follow-up was 2.97 years. No relation between baseline NTproCNP or its rate of change over 6 months and mortality was found. NTproCNP levels remained stable in HD patients, whereas NTproCNP decreased significantly in HDF patients. The relative decline depended on the magnitude of the convection volume. CONCLUSIONS: In our study, levels of NTproCNP appear strongly elevated in prevalent dialysis patients. Second, while NTproCNP remains unaltered in HD patients, its levels decline in individuals treated with HDF, with the decline dependent on the magnitude of the convection volume. Third, NTproCNP is not related to mortality in this population. Thus NTproCNP does not seem to be a useful marker for mortality risk in dialysis patients.
Fichier principal
Vignette du fichier
sfz156.pdf (547.34 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03327669 , version 1 (27-08-2021)

Identifiers

Cite

C. L. M. de Roij Van Zuijdewijn, L. H. A. Van Gastel, P. M. ter Wee, M. L. Bots, P. J. Blankestijn, et al.. The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration. Clinical Kidney Journal, 2021, 14 (1), pp.375-381. ⟨10.1093/ckj/sfz156⟩. ⟨inserm-03327669⟩
17 View
13 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More